Morgan Stanley
ENZY

Morgan Stanley’s Enzymotec Ltd ENZY Stock Holding History

Morgan Stanley’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-187,170
Closed -$2.22M – 6878
2017
Q4 		$2.22M Buy
+187,170
New +$2.17M ﹤0.01% 3944
2017
Q1 		– Sell
-5,311
Closed -$35K – 6683
2016
Q4 		$35K Buy
5,311
+300
+6% +$1.98K ﹤0.01% 5847
2016
Q3 		$35K Sell
5,011
-7,197
-59% -$57.7K ﹤0.01% 5735
2016
Q2 		$102K Sell
12,208
-42,961
-78% -$356K ﹤0.01% 5232
2016
Q1 		$498K Buy
55,169
+6,683
+14% +$58.2K ﹤0.01% 4447
2015
Q4 		$475K Buy
48,486
+33,288
+219% +$315K ﹤0.01% 4580
2015
Q3 		$137K Buy
15,198
+6,459
+74% +$57.6K ﹤0.01% 5273
2015
Q2 		$73K Buy
8,739
+5,283
+153% +$48.5K ﹤0.01% 5734
2015
Q1 		$25K Sell
3,456
-10,899
-76% -$77.1K ﹤0.01% 5998
2014
Q4 		$110K Buy
14,355
+9,199
+178% +$66.8K ﹤0.01% 5509
2014
Q3 		$35K Buy
5,156
+3,926
+319% +$42.4K ﹤0.01% 5841
2014
Q2 		$17K Sell
1,230
-10,027
-89% -$168K ﹤0.01% 6070
2014
Q1 		$248K Sell
11,257
-695
-6% -$18.4K ﹤0.01% 5008
2013
Q4 		$323K Buy
+11,952
New +$284K ﹤0.01% 4775

Morgan Stanley's ENZY Position: Q1 2018 in Review

Morgan Stanley sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 187,170 shares — an estimated $2.22M sold.

Morgan Stanley first reported a position in ENZY in Q4 2013 and held it in 14 quarters. The position peaked at $2.22M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

  • Morgan Stanley reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
  • Morgan Stanley sold 187,170 Enzymotec Ltd shares in Q1 2018, an estimated $2.22M.
  • Morgan Stanley first reported a position in Enzymotec Ltd in Q4 2013 and held it in 14 quarters.
  • Morgan Stanley's Enzymotec Ltd position peaked at $2.22M in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.